Consumer medicine information

Avil

Pheniramine maleate

BRAND INFORMATION

Brand name

Avil

Active ingredient

Pheniramine maleate

Schedule

S3

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using Avil.

What is in this leaflet

This leaflet answers some common questions about Avil. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

All medicines have risks and benefits. Your doctor or pharmacist has weighed the risks of you taking this medicine against the benefits they expect it will have for you.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Keep this leaflet. You may need to read it again.

What Avil is used for

Avil Tablets contain pheniramine maleate, a medicine used to treat allergic conditions such as hayfever, runny nose, itching skin and skin rashes. It is also used in the prevention and treatment of nausea, vomiting and dizziness due to inner ear disorders (eg Meniere's disease) and travel sickness.

Avil is one of a group of medicines called 'antihistamines' which works by blocking the action of histamine.

Before you take Avil

When you must not take it

Do not take Avil if you:

  • are taking an antidepressant medicine known as a MAO Inhibitor
  • are male and you have an enlarged prostate

Do not give Avil to a premature or newborn baby.

Do not take Avil if you are allergic to it or any of the ingredients listed at the end of this leaflet. Some symptoms of an allergic reaction include skin rash, itching, asthma, wheezing, shortness of breath or swelling of the fact, lips or tongue, which may cause difficulty in swallowing or breathing, fainting.

Contains lactose and sugars.

Do not take it after the expiry date (EXP) printed on the pack. If you take it after the expiry date has passed, it may not work as well.

Do not take it if the packaging is torn or shows signs of tampering.

Before you start to take it

Tell your doctor if you have allergies to

  • any of the ingredients listed at the end of this leaflet
  • any other medicines
  • any other substances, such as foods, preservatives or dyes.

Tell your doctor or pharmacist if you are pregnant or intend to become pregnant. Your doctor or pharmacist will discuss the risk and benefits of taking it if you are pregnant.

Tell your doctor or pharmacist if you are breastfeeding or planning to breastfeed. If there is a need to consider Avil while you are breastfeeding, your doctor or pharmacist will discuss with you the benefits and risks of taking it.

Tell your doctor or pharmacist if you have or have had any medical conditions, especially the following:

  • an enlarged prostate
  • glaucoma (high pressure in the eye)
  • breathing problems, including asthma or bronchitis
  • heart disease

Tell your doctor or pharmacist if you plan to have surgery.

If you have not told your doctor or pharmacist about any of the above, tell them before you take Avil.

Taking other medicines

Tell your doctor or pharmacist if you are taking any other medicines, including any that you buy without a prescription from your pharmacy, supermarket or health food store.

Some medicines and Avil may interfere with each other. These include:

  • antidepressants known as MAO inhibitors
  • atropine and other anticholinergic drugs (such as medicines used to relieve stomach cramps or spasms, to prevent travel sickness and to treat Parkinson's disease)
  • alcohol
  • sedative drugs

Your doctor or pharmacist has more information on medicines to be careful with or to avoid while taking Avil.

Avil may cause drowsiness and may increase the effects of alcohol and other sedative drugs. If affected, do not drive a motor vehicle or operate machinery. You might get used to the sedative effect after a few days of treatment, however you may prefer to change to a non-sedating antihistamine.

Please discuss this option with your pharmacist.

How to take Avil

How much to take

Adults and children over 10 years:
Half to 1 tablet up to 3 times daily.

Children 5-10 years:
Half a tablet up to 3 times daily.

Not recommended for children under 5 years of age.

To prevent travel sickness, it is recommended that the first dose be taken at least 30 minutes before travelling.

Ask your doctor or pharmacist if you are unsure of the correct dose for you. They will tell you exactly how much to take.

How to take it

Avil should be swallowed with plenty of water. Do not chew them.

When to take it

Avil should be taken with or soon after food. Do not take the medicine on an empty stomach.

If you are taking Avil to prevent travel sickness, take a dose at least 30 minutes before travelling.

If you are not sure when to take Avil, ask your doctor or pharmacist.

How long to take it

Ask your doctor or pharmacist if you are not sure how long to take this medicine for.

If you forget to take or give a dose

If it is almost time for your next dose, skip the dose you missed and take your next dose when you are meant to. Otherwise, take it as soon as you remember, and then go back to taking your dose as you would normally. Do not take a double dose to make up for the dose that you missed.

If you take too much (overdose)

Immediately telephone your doctor or Poisons Information Centre (telephone 13 11 26) or go to Accident and Emergency at your nearest hospital if you think that you or anyone else may have taken too much Avil.

Do this even if there are no signs of discomfort or poisoning. You may need urgent medical attention.

While you are taking Avil

Things you must do

Tell all the doctors, dentists and pharmacists who are treating you that you are taking Avil.

If you are about to be started on any new medicine, tell your doctor and pharmacist that you are taking Avil.

If you need to have an allergy test, tell your doctor that you are taking Avil.

If you become pregnant while taking Avil, tell your doctor or pharmacist.

Things you must not do

Do you take more than the recommended dose unless your doctor or pharmacist tells you to.

Things to be careful of

Avil can cause drowsiness so you should not drive a motor vehicle or operate machinery after taking a dose. This effect may decrease with time.

Side effects

All medicines can have some unwanted side effects. Sometimes they are serious, most of the time they are not. Your doctor or pharmacist has weighed the risks of using this medicine against the benefits they expect it will have for you. Do not be alarmed by this list of possible side effects. You may not experience any of them.

Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking Avil.

Tell your pharmacist or doctor if you notice any of the following and they worry you:

  • drowsiness
  • nervousness, irritability, incoordination, lack of concentration
  • tiredness or weariness
  • dizziness
  • buzzing, hissing, whistling, ringing or other persistent noise in the ears
  • nausea and vomiting
  • diarrhoea
  • stomach pain
  • difficulty passing urine
  • trouble sleeping
  • shaking
  • loss of appetite
  • dryness of mouth
  • constipation
  • looking pale

Tell your doctor immediately if you notice any of the following:

  • changes in your usual behaviour or mood
  • severe sedation, confusion or restlessness
  • waves of sudden severe stomach pain
  • hallucinations
  • vision problems
  • irregular heart beat
  • headache
  • frequent infections such as fever, severe chills, sore throat or mouth ulcers

If any of the following happen, stop taking this medicine and tell your doctor immediately, or go to Accident and Emergency at your nearest hospital:

  • swelling of the face, lips, mouth or throat, which may cause difficulty in swallowing or breathing
  • hives
  • fainting
  • yellowing of the skin and eyes (jaundice)

Agitation and convulsions, and sometimes death, especially in children and restlessness, disorientation and hallucinations in adults, are common symptoms following overdose.

These may be serious side effects. You may need urgent medical attention. Serious side effects are rare.

Ask your doctor or pharmacist to answer any questions you may have.

After taking Avil

If you have any queries about any aspect of your medicine, or any questions regarding the information in this leaflet, discuss them with your doctor or pharmacist.

Storage

Keep your tablets in the blister pack until it is time to take them. If you take the tablets out of the box or the blister pack, they may not keep well.

Keep Avil in a cool dry place where the temperature stays below 30°C. Do not store Avil or any other medicine in the bathroom or near a sink. Do not leave it in the car or on window sills. Heat and dampness can destroy some medicines.

Keep it where children cannot reach it. A locked cupboard at least one-and-a-half metres above the ground is a good place to store medicines.

Disposal

If your doctor tells you to stop taking it or the expiry date has passed, ask your pharmacist what to do with any medicine that is left over.

Return any unused medicine to your pharmacist.

Product description

What it looks like

Avil tablets are round white tablets with DAR on one side of the tablet and DAR on each side of a score line on the other side of the tablet. They come in packs of 10 and 50* tablets.

*Packs currently not marketed in Australia

Ingredients

Active ingredients:

Avil tablets contain the active ingredient pheniramine maleate.

There is 45.3 mg of pheniramine maleate in every tablet.

Inactive ingredients:

  • maize starch
  • lactose monohydrate
  • magnesium stearate
  • pregelatinized maize starch
  • silicon dioxide

Avil preparations do not contain gluten, tartrazine or azo dyes.

Sponsor

Avil tablets supplied in Australia by:

sanofi-aventis australia pty ltd
12-24 Talavera Road
Macquarie Park NSW 2113

Australian Register Number 191053

This leaflet was prepared in February 2020

® Registered Trademark

avil-ccdsv01-cmiv2-13feb20

Published by MIMS July 2020

BRAND INFORMATION

Brand name

Avil

Active ingredient

Pheniramine maleate

Schedule

S3

 

1 Name of Medicine

Pheniramine maleate.

6.7 Physicochemical Properties

Pheniramine maleate is a white or almost white crystalline powder that is soluble in water (1 in 0.3), alcohol (1 in 2.5) and chloroform (1 in 1.5). A 1% solution in water has a pH of 4.5 to 5.5.

Chemical structure.


CAS number.

132-20-7.

2 Qualitative and Quantitative Composition

Avil tablets contains pheniramine maleate 45.3 mg per tablet.

Excipients of known effect.

Lactose monohydrate.
For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

White tablets, marked DAR on one side of the tablet and DAR on each side of a score line on the other side of the tablet.

5 Pharmacological Properties

5.1 Pharmacodynamic Properties

Mechanism of action.

Pheniramine is a member of the alkylamine class of H1-receptor antagonists. The H1 antagonists inhibit the effect of histamine on capillary permeability and on vascular, bronchial and many other types of smooth muscle. They can both stimulate and depress the CNS; however, the usual effect of therapeutic doses is CNS depression. The alkylamine antihistamines also possess anticholinergic and local anaesthetic properties.

Clinical trials.

No data available.

5.2 Pharmacokinetic Properties

Absorption and distribution.

Pheniramine is readily absorbed from the gastrointestinal tract.
Following oral administration, the effects start within 15 to 30 minutes and are fully developed within 1 hour. Peak plasma concentrations are reached in 1 to 2.5 hours.

Metabolism and excretion.

After oral administration, the terminal half-life is between 16 and 19 hours, and the total recovery of pheniramine as unchanged drug and N-desmethylpheniramine and N-didesmethylpheniramine metabolites from the urine is 70-83% of the dose.

5.3 Preclinical Safety Data

Genotoxicity.

No data available.

Carcinogenicity.

No data available.

4 Clinical Particulars

4.1 Therapeutic Indications

Allergic conditions including hay fever, drug rashes, angioneurotic oedema, serum sickness, allergic conjunctivitis, food allergy, etc.
Conditions of the respiratory tract that are accompanied by increased secretion, including vasomotor rhinitis and acute rhinitis.
All itching skin conditions, including neurodermatitis, eczema of any origin, lichen planus, acute and chronic urticaria, pruritus of the anus or genitals, pruritus in icterus and diabetes, radiation sickness, etc.
Prevention and treatment of motion sickness.
Prevention and treatment of nausea, vomiting and vertigo due to Menière's disease and other labyrinthine disturbances.

4.3 Contraindications

Patients with hypersensitivity to pheniramine or any other ingredient (e.g. methyl hydroxybenzoate or propyl hydroxybenzoate in the syrup).
Patients with symptomatic prostatic hypertrophy.
Patients receiving MAO inhibitor therapy.
Newborn and premature infants.

4.4 Special Warnings and Precautions for Use

Pheniramine may cause drowsiness (see Section 4.7 Effects on Ability to Drive and Use Machines).
Patients should be cautioned against the simultaneous ingestion of alcohol and other central nervous system depressants. Pheniramine may possibly be hallucinogenic in toxic doses. Due to the possible CNS stimulating effects of antihistamines, pheniramine has the potential for abuse.
Due to the anticholinergic effect of pheniramine, caution and close monitoring are required if it is used in patients with conditions such as prostatic hypertrophy, narrow angle glaucoma, asthma or severe cardiovascular disease.
The anti-emetic effect of pheniramine may mask the signs of other conditions.
Products containing pheniramine should not be taken on an empty stomach.

Use in the elderly.

See Section 4.2 Dose and Method of Administration for information on elderly dosing.

Paediatric use.

See Section 4.2 Dose and Method of Administration for information on paediatric dosing.

Effects on laboratory tests.

Antihistamines may suppress the cutaneous histamine response to allergen extracts and should be stopped several days before skin testing.

4.5 Interactions with Other Medicines and Other Forms of Interactions

MAO inhibitors may prolong and intensify the anticholinergic effect of pheniramine (see Section 4.3 Contraindications).
Adverse CNS effects of pheniramine may be enhanced when it is taken with alcohol or other CNS depressants (e.g. hypnotics, sedatives, tranquilizers).
Atropine and related drugs may enhance the anticholinergic activity of pheniramine.

4.6 Fertility, Pregnancy and Lactation

Effects on fertility.

No data available.
(Category A)
Use only if strictly indicated.
There are no available data on the presence of Avil use in pregnant women. No conclusions can be drawn regarding whether or not Avil is safe for use during pregnancy. Avil should be used during pregnancy only if the potential benefits outweigh the potential risks, including those to the foetus.
Use only if strictly indicated.
There are no available data on the presence of Avil use in human milk, milk production, or the effects on the breastfed infant. No conclusions can be drawn regarding whether or not Avil is safe for use during breastfeeding. Avil should be used during breastfeeding only if the potential benefits to the mother outweigh the potential risks, including those to the breastfed child.

4.8 Adverse Effects (Undesirable Effects)

Preparations containing pheniramine are generally well tolerated. The most common adverse reaction is sedation, which often disappears after a few days if tolerance is acquired. Hypersensitivity reactions have been reported.

Central nervous system.

Lassitude, dizziness, tinnitus, inability to concentrate, incoordination, irritability, insomnia and tremors. Agitation and convulsions, especially in children, and restlessness, disorientation and hallucinations in adults, are common symptoms following overdose.

Gastrointestinal.

Nausea, vomiting, diarrhoea, colic, epigastric pain, anorexia, dryness of mouth and constipation.

Genitourinary.

Urinary retention.

Cardiovascular.

Palpitations, headache.

Ocular.

Blurred vision, increased intraocular pressure.

Musculoskeletal.

Muscular weakness.

Haematological.

Rare cases of blood dyscrasias, including agranulocytosis and haemolytic anaemia, have been reported.

Reporting suspected adverse effects.

Reporting suspected adverse reactions after registration of the medicinal product is important. It allows continued monitoring of the benefit-risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions at www.tga.gov.au/reporting-problems (Australia) or https://nzphvc.otago.ac.nz/reporting/ (New Zealand).

4.2 Dose and Method of Administration

Doses must be individually determined in all cases and should be taken with or soon after food. Treatment should be commenced at the lowest possible dose because experience has shown that antihistamines are often effective at low doses. The maximum dose of 3 mg/kg per day should not be exceeded. Elderly patients should use the adult dose with caution.
To prevent travel sickness, it is recommended that the first dose be taken at least 30 minutes before travelling. Due to the risk of drowsiness, the patient should not drive a motor vehicle or operate machinery after taking a dose.

Avil tablets.

In adults and children over 10 years of age, treatment is commenced with half a tablet taken up to three times daily. This dose may be increased to one tablet taken up to three times daily if required.

Children 5-10 years of age.

Half a tablet up to three times daily. Avil tablets are not recommended in children under 5 years of age.

4.7 Effects on Ability to Drive and Use Machines

Pheniramine may cause drowsiness. If affected, do not drive a vehicle or operate machinery. Both the dosage and the time of administration should be carefully considered in patients whose activities (e.g. driving a car or operating machinery) demand special concentration. Patients who cannot tolerate the sedative effects should consider swapping to a non-sedating antihistamine such as Telfast (fexofenadine).

4.9 Overdose

Symptoms.

Antihistamine drugs in toxic doses produce a complex of CNS excitatory and depressant effects. Accidental ingestion in small children has resulted in convulsions and sometimes death.

Management.

In the event of overdose of Avil, take all appropriate measures immediately.
As there is no known specific antidote for pheniramine overdose, treatment should be symptomatic and supportive. Induction of vomiting should only be used immediately after ingestion as the sedative action of any absorbed antihistamine can lead to life-threatening pulmonary aspiration during emesis. Gastric lavage with a cuffed endotracheal tube in situ may be useful for some time after ingestion of antihistamines as their anticholinergic action slows down gastric emptying.
Stimulants should not be used as they may precipitate convulsions. Diazepam or short-acting barbiturates may be used to control convulsions. Vasopressors may be used to treat hypotension. Mechanical support of respiration may be required if respiration is seriously depressed. Continuous ECG monitoring is recommended if cardiac toxicity develops, which can be treated with centrally-acting anticholinesterases such as physostigmine.
For information on the management of overdose, contact the Poison Information Centre on 13 11 26 (Australia).

7 Medicine Schedule (Poisons Standard)

(S3) Pharmacist-Only Medicine.

6 Pharmaceutical Particulars

6.1 List of Excipients

The tablets contain maize starch, lactose monohydrate, pregelatinized maize starch, silicon dioxide and magnesium stearate.

6.2 Incompatibilities

Incompatibilities were either not assessed or not identified as part of the registration of this medicine.

6.3 Shelf Life

In Australia, information on the shelf life can be found on the public summary of the Australian Register of Therapeutic Goods (ARTG). The expiry date can be found on the packaging.

6.4 Special Precautions for Storage

Store below 30°C. Protect from light.

6.5 Nature and Contents of Container

Avil tablets: in packs of 10 or 50 tablets*.
*Packs currently not marketed in Australia.

6.6 Special Precautions for Disposal

In Australia, any unused medicine or waste material should be disposed of by taking to your local pharmacy.

Summary Table of Changes